Stephen Betz
Founder bij CRINETICS PHARMACEUTICALS, INC.
Vermogen: 4 M $ op 31-03-2024
Profiel
Stephen F.
Betz is the founder.
He founded Crinetics Pharmaceuticals, Inc. in 2008 and currently holds the title of Chief Scientific Officer.
He previously worked at Neurocrine Biosciences, Inc. from 2003 to 2009, where he held the position of Director-Endocrinology & Metabolism.
Before that, he worked at GeneFormatics, Inc. from 2001 to 2003 as the Head-Laboratory Efforts.
Mr. Betz completed his undergraduate degree at the University of Delaware in 1987.
He then went on to earn his doctorate degree from The University of North Carolina at Chapel Hill in 1993.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2024 | 92 643 ( 0.12% ) | 4 M $ | 31-03-2024 |
Actieve functies van Stephen Betz
| Bedrijven | Functie | Begin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 01-01-2008 |
Eerdere bekende functies van Stephen Betz
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01-05-2009 |
| GeneFormatics, Inc. | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Stephen Betz
| University of Delaware | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| GeneFormatics, Inc. | Health Technology |
